Abstract
Clavulanic acid, a beta-lactamase inhibitor, was found to be associated with the development of a positive direct antiglobulin test. Of 23 antibiotic courses in patients treated with ticarcillin, clavulanic acid, and tobramycin, 10 (43.5%) developed positive direct antiglobulin tests versus 2 of 26 (7.7%) patients treated with piperacillin and tobramycin (P = 0.0044). In vitro immunohematological studies showed that clavulanic acid caused a nonimmunologic adsorption of plasma proteins onto the erythrocyte surface. Hemolysis was not associated with such nonimmunologic adsorption. However, the resulting positive antiglobulin test might delay cross matching of blood products for transfusions or interfere with the evaluation of true immune-mediated hemolytic anemia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Garratty G., Petz L. D. Drug-induced immune hemolytic anemia. Am J Med. 1975 Mar;58(3):398–407. doi: 10.1016/0002-9343(75)90606-3. [DOI] [PubMed] [Google Scholar]
- Kirtland H. H., 3rd, Mohler D. N., Horwitz D. A. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med. 1980 Apr 10;302(15):825–832. doi: 10.1056/NEJM198004103021502. [DOI] [PubMed] [Google Scholar]
- Molthan L., Reidenberg M. M., Eichman M. F. Positive direct Coombs tests due to cephalothin. N Engl J Med. 1967 Jul 20;277(3):123–125. doi: 10.1056/NEJM196707202770303. [DOI] [PubMed] [Google Scholar]